SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the fourth quarter and full-year 2023 before U.S. markets open on Tuesday, March 5, 2024. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET.

The call will be webcast live on the SOPHiA GENETICS Investor Relations website. Additionally, a replay will be available on the website after its completion.

About SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH) is a software company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products, and services are currently used by a broad network of hospital, laboratory, and biopharma institutions globally. For more information, visit SOPHiAGENETICS.COM, or connect on X, LinkedIn, Facebook, and Instagram. Where others see data, we see answers.

Investor Contact
Kellen Sanger
IR@sophiagenetics.com

Media Contact
Kelly Katapodis
media@sophiagenetics.com
Sophia Genetics (NASDAQ:SOPH)
過去 株価チャート
から 10 2024 まで 11 2024 Sophia Geneticsのチャートをもっと見るにはこちらをクリック
Sophia Genetics (NASDAQ:SOPH)
過去 株価チャート
から 11 2023 まで 11 2024 Sophia Geneticsのチャートをもっと見るにはこちらをクリック